Premium
How I treat older patients with acute myeloid leukemia
Author(s) -
Arellano Martha,
Carlisle Jennifer Wilkinson
Publication year - 2018
Publication title -
cancer
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 3.052
H-Index - 304
eISSN - 1097-0142
pISSN - 0008-543X
DOI - 10.1002/cncr.31347
Subject(s) - medicine , myeloid leukemia , risk stratification , intensive care medicine , leukemia , myeloid , oncology
Acute myeloid leukemia (AML) in the elderly represents a challenge to the clinician due to AML‐related and patient‐related factors that place patients at an increased risk of induction toxicity and limit treatment options. To make gains in the management of the elderly patient with AML, clinicians must focus on improved risk stratification and develop better‐tolerated active regimens.